Table 2 –
Group Descriptive Statistics.
| Demographic Model (N = 147) | Health Model (N = 106) | |
|---|---|---|
|
| ||
| Age at stroke (years) | ||
| M(SD) | 56.0 (12.1) | 56.0 (12.0) |
| Range | 27.0–80.0 | 27.0–79.0 |
| Sex, n (%) | ||
| Female | 56 (38%) | 37 (35%) |
| Male | 91 (62%) | 69 (65%) |
| Education (years) | ||
| M(SD) | 15.2 (2.3) | 15.6 (2.2) |
| Range | 10.0–20.0 | 12.0–20.0 |
| SES (USD) | ||
| M(SD) | $60,511.22 ($20,038.43) | $58,814.29 ($19,314.50) |
| Range | $23,086-$113,802 | $23,086-$111,250 |
| WAB-AQ | ||
| M(SD) | 62.5 (26.0) | 62.2 (24.7) |
| Range | 5.6–99.6 | 5.6–99.6) |
| WAIS Matrices | ||
| M (SD) | 10.1 (3.7) | 10.3 (3.6) |
| Range | .0–23.0 | .0–23.0 |
| Lesion Volume | ||
| M (SD) | 123,590 (96,471) | 120,588 (93,177) |
| Range | 117–467,458 | 117–467,458 |
| Prop. Damage ROIs | ||
| M (SD) | .53 (.3) | .52 (.3) |
| Range | .0–1.0 | .0–1.0 |
| Exercise >30 min/week | ||
| M (SD) | NA | 3.6 (2.5) |
| Range | .0–14.0 | |
| Body Mass Index | ||
| M (SD) | NA | 27.3 (5.4) |
| Range | 17.4–47.3 | |
| Fazekas Rating | ||
| M (SD) | NA | 3.3 (1.6) |
| Range | .0–6.0 | |
| Diabetes, n (%) | ||
| Present | NA | 21 (20%) |